At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $41.32M, above the global median of $18.58M
- PositionCurrent ratio is 1.23×, lower than 95% of its Scientific & Technical Instruments peers (median 2.38×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.32BCNY803.29M · vs all stocks (USD)
Revenue (TTM)
3.02BCNY441.33M · vs all stocks (USD)
Profit Margin
-8.10%vs Scientific & Technical Instruments peers
Beta
0.2040xvs all stocks
52-Week Change
-36.73%vs all stocks
Market Capitalization
4.32BCNY803.29M · vs all stocks (USD)
Enterprise Value
6.32BCNY1.11B · vs all stocks (USD)
Forward P/E
16.83xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
1.44xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
1.64xvs Scientific & Technical Instruments peers
Enterprise to Revenue
2.09xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
-107.93xvs Scientific & Technical Instruments peers
Gross Margin
39.78%vs Scientific & Technical Instruments peers
Profit Margin
-8.10%vs Scientific & Technical Instruments peers
Operating Margin
-7.83%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
-1.71%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
-9.76%vs Scientific & Technical Instruments peers
Revenue (TTM)
3.02BCNY441.33M · vs all stocks (USD)
Revenue per Share (TTM)
6.85CNYUpdated Nov 22, 2026Quarterly Revenue Growth
9.60%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
1.12BCNY161.07M · vs all stocks (USD)
EBITDA (TTM)
144.47MCNY21.64M · vs all stocks (USD)
Net Income (TTM)
-244.47MCNY-40.18M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
52.27%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
555.87MCNY80.27M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
236.79MCNY41.32M · vs all stocks (USD)
5-Year Average Dividend Yield
0.24%vs all stocks
Payout Ratio
416.67%vs Scientific & Technical Instruments peers
Minority Interest (Equity)
225.73MCNYFY2025 · Dec 31, 2025Revenue
3.00BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.85BCNYFY2025 · Dec 31, 2025Gross Profit
1.14BCNYFY2025 · Dec 31, 2025Operating Income
-55.81MCNY-8.36M · vs all stocks (USD)
Pre-tax Income
-269.98MCNYFY2025 · Dec 31, 2025Income Tax Expense
5.07MCNYFY2025 · Dec 31, 2025Net Income
-275.05MCNYFY2025 · Dec 31, 2025EBIT
-132.89MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
144.47MCNYFY2025 · Dec 31, 2025Research & Development
387.67MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
361.59MCNYFY2025 · Dec 31, 2025Other Operating Expenses
38.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.05MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
137.09MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.5200CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.5200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
447.38MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
447.38MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-275.05MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
42.41MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
314.33MCNYFY2025 · Dec 31, 2025Free Cash Flow
289.19MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
974.75MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-275.05MCNYFY2025 · Dec 31, 2025Other Non-cash Items
139.39MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
309.43MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
140.57MCNYFY2025 · Dec 31, 2025Capital Expenditures
-25.15MCNYFY2025 · Dec 31, 2025Purchase of Investments
-21.94MCNYFY2025 · Dec 31, 2025Sale of Investments
18.94MCNYFY2025 · Dec 31, 2025Other Investing Activity
3.28MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-24.87MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.20BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.44BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-235.21MCNYFY2025 · Dec 31, 2025Other Financing Charges
-132.69MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-614.02MCNYFY2025 · Dec 31, 2025Shares Outstanding
448.74MSharesUpdated Nov 22, 2026Float Shares
323.60MSharesUpdated Nov 22, 2026% Held by Insiders
29.25%vs all stocks
% Held by Institutions
6.37%vs all stocks
Total Cash (MRQ)
1.36BCNY224.29M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.10CNYUpdated Nov 22, 2026Total Debt (MRQ)
3.30BCNY511.72M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.21xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
1.25xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
5.86CNYUpdated Nov 22, 2026Total Assets
8.49BCNY1.27B · vs all stocks (USD)
Total Current Assets
3.49BCNYFY2025 · Dec 31, 2025Total Liabilities
5.60BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.00BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.81BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.79BCNYFY2025 · Dec 31, 2025Cash
975.14MCNYFY2025 · Dec 31, 2025Cash Equivalents
195.02MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.17BCNYFY2025 · Dec 31, 2025Accounts Receivable
692.08MCNYFY2025 · Dec 31, 2025Inventory
1.12BCNYFY2025 · Dec 31, 2025Accounts Payable
904.44MCNYFY2025 · Dec 31, 2025Short-term Debt
670.51MCNYFY2025 · Dec 31, 2025Other Current Liabilities
88.43MCNYFY2025 · Dec 31, 2025Long-term Debt
2.39BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
64.88MCNYFY2025 · Dec 31, 2025Common Stock (Book)
448.74MCNYFY2025 · Dec 31, 2025Retained Earnings
1.23BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.89BCNY433.17M · vs all stocks (USD)
Treasury Stock
107.01MCNYFY2025 · Dec 31, 202552-Week Low
9.60CNYUpdated Nov 22, 202652-Week High
17.22CNYUpdated Nov 22, 202652-Week Change
-36.73%vs all stocks
Beta
0.2040xvs all stocks
50-Day MA
12.29CNYUpdated Nov 22, 2026200-Day MA
13.23CNYUpdated Nov 22, 2026Avg 10-Day Volume
7.50MSharesUpdated Nov 22, 2026Avg 30-Day Volume
8.60MSharesUpdated Nov 22, 2026Diluted EPS (TTM)
-0.5500CNYUpdated Nov 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 1.23×, lower than 95% of its Scientific & Technical Instruments peers (median 2.38×)Significant
Current ratio: 1.23Industry median: 2.38Industry P5: 1.26Peers compared: 64.00
Debt-to-equity is 1.23×, higher than 95% of its Scientific & Technical Instruments peers (median 0.13×)Significant
Debt-to-equity: 1.23Industry median: 0.13Industry P95: 1.00Peers compared: 64.00
Financial Health
Altman Z-Score 1.18: grey zoneSignificant
Altman Z-Score: 1.18
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Levered free cash flow is $41.32M, above the global median of $18.58MNotable
Levered free cash flow (USD): 41,318,996.051Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Hongchang Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hiconics Eco-Energy Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong Highsun Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Canlon Building Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changzhou Galaxy Century Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Krishana Phoschem Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Seikoh Giken Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Ankura Intelligent Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Tinavi Medical Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Latham Group, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule